Alpha 2.0
Login Register
» Authors » Vandana Kulkarni

Vandana Kulkarni

Explore the profile of Vandana Kulkarni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 509
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Science
Top 10 Co-Authors
Amita Gupta
Vidya Mave
Nikhil Gupte
Prasad Deshpande
Mandar Paradkar
Renu Bharadwaj
Ramesh Bhosale
Nishi Suryavanshi
Aarti Kinikar
Anju Kagal
Published In
PLoS One
Clin Infect Dis
J Infect Dis
Open Forum Infect Dis
J Acquir Immune Defic Syndr
Affiliations
Soon will be listed here.
Recent Articles
1.
HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India
Mathad J, Alexander M, Bhosale R, Naik S, Cranmer L, Kulkarni V, et al.
Open Forum Infect Dis . 2025 Mar; 12(3):ofaf047. PMID: 40046890
Background: Maternal HIV infection can affect placental immunology and expression of the neonatal crystallizable fragment receptor (FcRn), which allows transplacental antibody transfer. This study delineated differences in placental FcRn and...
2.
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis
Palmer M, Zou Y, Hesseling A, van der Laan L, Courtney I, Kinikar A, et al.
Br J Clin Pharmacol . 2025 Feb; PMID: 39957395
Aims: Moxifloxacin is a priority drug for treating rifampicin-resistant tuberculosis (RR-TB). We assessed the pharmacokinetics of a child-friendly, dispersible 100 mg tablet moxifloxacin formulation (dispersed in water) compared to the...
3.
Discordance of 3rd and 4th generation QuantiFERON-TB Gold assays by pregnancy stages in India
Kulkarni V, Alexander M, Bhosale R, Jain D, Deshpande P, Gitlin E, et al.
J Clin Tuberc Other Mycobact Dis . 2025 Jan; 38:100504. PMID: 39758562
Background: Pregnancy and HIV affect CD4+ T lymphocytes and impact performance of QuantiFERON-TB Gold (QFT). We compared the results of QFT with QuantiFERON-TB Gold Plus (QFT-Plus), which also measures CD8+...
4.
Predictive metabolite signatures for risk of progression to active TB from QuantiFERON supernatants of household contacts of TB patients
Daniel E, Upadhyay S, Selvachithiram M, Pattabiraman S, Bhanu B, Sivaprakasam A, et al.
Emerg Microbes Infect . 2024 Dec; 14(1):2437242. PMID: 39628384
The identification of individuals with the greatest risk of progression to active tuberculosis (TB) disease from the huge reservoir of () infected individuals continues to remain an arduous ascent in...
5.
Plasma Immune Biomarkers Predictive of Progression to Active Tuberculosis in Household Contacts of TB Patients
Rajamanickam A, Daniel E, Dasan B, Thiruvengadam K, Chandrasekaran P, Gaikwad S, et al.
J Infect Dis . 2024 Jul; PMID: 39028003
Background: The progression from Mycobacterium tuberculosis infection to active tuberculosis (TB) disease varies among individuals, and identifying biomarkers to predict progression is crucial for guiding interventions. In this study, we...
6.
The sound of silent RNA in tuberculosis and the lncRNA role on infection
Rocha E, Vinhaes C, Araujo-Pereira M, Mota T, Gupte A, Kumar N, et al.
iScience . 2024 Jan; 27(1):108662. PMID: 38205253
Tuberculosis (TB) is one of the leading causes of death worldwide, and Diabetes Mellitus is one of the major comorbidities (TB/DM) associated with the disease. A total of 103 differentially...
7.
Clinically relevant antibiotic resistance genes are linked to a limited set of taxa within gut microbiome worldwide
Diebold P, Rhee M, Shi Q, Trung N, Umrani F, Ahmed S, et al.
Nat Commun . 2023 Nov; 14(1):7366. PMID: 37963868
The acquisition of antimicrobial resistance (AR) genes has rendered important pathogens nearly or fully unresponsive to antibiotics. It has been suggested that pathogens acquire AR traits from the gut microbiota,...
8.
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial
Gupta A, Singh P, Aaron L, Montepiedra G, Chipato T, Stranix-Chibanda L, et al.
Lancet Child Adolesc Health . 2023 Aug; 7(10):708-717. PMID: 37634517
Background: Infants born to women with HIV in settings with a high tuberculosis burden are at risk of tuberculosis infection and rapid progression to active disease. Maternal isoniazid preventive therapy...
9.
Comparative immune responses to in people with latent infection or sterilizing protection
Jalbert E, Liu C, Mave V, Lang N, Kagal A, Valvi C, et al.
iScience . 2023 Aug; 26(8):107425. PMID: 37564701
There is great need for vaccines against tuberculosis (TB) more efficacious than the licensed BCG. Our goal was to identify new vaccine benchmarks by identifying immune responses that distinguish individuals...
10.
Maternal Colonization Versus Nosocomial Transmission as the Source of Drug-Resistant Bloodstream Infection in an Indian Neonatal Intensive Care Unit: A Prospective Cohort Study
Robinson M, Johnson J, Naik S, Patil S, Kulkarni R, Kinikar A, et al.
Clin Infect Dis . 2023 Jul; 77(Suppl 1):S38-S45. PMID: 37406039
Background: Drug-resistant gram-negative (GN) pathogens are a common cause of neonatal sepsis in low- and middle-income countries. Identifying GN transmission patterns is vital to inform preventive efforts. Methods: We conducted...